JCO Precision Oncology Conversations

JCO Precision Oncology Conversations

Por: American Society of Clinical Oncology (ASCO)
JCO Precision Oncology Conversations is a monthly podcast featuring conversations with authors of clinically relevant and significant articles published in the JCO Precision Oncology journal. JCO Precision Oncology Conversations is hosted by the journal's social media editor, Dr. Abdul Rafeh Naqash.
61 episodios disponibles

Latest episodes of the podcast JCO Precision Oncology Conversations

Mostrando página 3 de 4

Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy 20/03/2024
JCO PO Article Insights: Prediction of Adjuvant Pertuzumab Benefit by 80-GS 28/02/2024
MultiCancer Detection Test Performance in Symptomatic Individuals 21/02/2024
JCO PO Article Insights: Diverse Study Samples in Clinical Trials 31/01/2024
Tumor Mutational Burden and Advanced Pancreatic Cancer 24/01/2024
Representativeness of Lung-MAP Participants 20/12/2023
Perspectives on Universal Germline Testing for Colorectal Cancer 22/11/2023
Outcomes of the IMMray PanCan-d Test in High-Risk Individuals 26/10/2023
Implementation of the Maine Cancer Genomics Initiative 20/09/2023
Pertuzumab + Trastuzumab in Lung Cancer with ERBB2 Alterations 16/08/2023
MMR-P Colorectal Cancer in Lynch Syndrome 19/07/2023
Real-World NTRK Fusions and TRK Inhibitors in Veterans 21/06/2023
Larotrectinib for TRK Fusion - Positive Lung Cancer 17/05/2023
ctDNA for Recurrence Prediction in Esophagogastric Cancers 19/04/2023
KRAS Variants, G12C, TMB, high PD-L1 Expression in Solid Tumors 15/03/2023
Universal Genetic Germline Testing in Solid Tumor Cancer Patients 15/02/2023
Tumor Mutational Burden as a Predictor of First-Line Immune Checkpoint Inhibitor Versus Carboplatin Benefit in Cisplatin-Unfit Patients With Urothelial Carcinoma, with Dr. Shilpa Gupta 18/01/2023
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors, with Dr. Mark Stewart 21/12/2022
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures with Dr. Mark Yarchoan 16/11/2022
Hyperthermic Intraperitoneal Chemotherapy–Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer with Dr. Thanh Dellinger 19/10/2022
« Primera ‹ Anterior 1 2 3 4 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA